Absence of mutations in the growth hormone (GH)‐releasing hormone receptor gene in GH‐secreting pituitary adenomas

GH‐releasing hormone (GHRH) is a potent stimulator of somatotroph cell proliferation and GH secretion. GHRH acts via binding to a G‐protein coupled receptor (GPCR) (GHRH‐R), that activates adenylyl cyclase (AC) and increases growth and function of somatotroph cells. Indeed, a subset (30–40%) of somatotrophic adenomas contain somatic mutations of the GNAS1 gene that encodes the alpha subunit of the G‐protein (Gsα) that stimulates AC. As activating mutations of other GPCRs cause development of endocrine tumours, we hypothesized that somatic activating mutations of the GHRH‐R might provide the molecular basis for somatotroph cell proliferation in a subset of human GH‐secreting pituitary adenomas.

[1]  M. Buchfelder,et al.  A polymorphism in the growth hormone (GH)-releasing hormone (GHRH) receptor gene is associated with elevated response to GHRH by human pituitary somatotrophinomas in vitro. , 2000, Biochemical and biophysical research communications.

[2]  D. Lüdecke,et al.  Absence of somatostatin receptor type 2 A mutations and gip oncogene in pituitary somatotroph adenomas , 2000, Clinical endocrinology.

[3]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[4]  D. Doyle,et al.  Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. , 1999, The New England journal of medicine.

[5]  K. Miller,et al.  Denaturing gradient gel electrophoresis (DGGE): a rapid and sensitive technique to screen nucleotide sequence variation in populations. , 1999, BioTechniques.

[6]  B. Gaylinn Molecular and cell biology ofthe growth hormone-releasing hormone receptor , 1999 .

[7]  F. Gracia‐Navarro,et al.  Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations. , 1999, Endocrinology.

[8]  M. Levine,et al.  Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. , 1999, The Journal of clinical endocrinology and metabolism.

[9]  L. Brooks,et al.  A DNA polymorphism discovery resource for research on human genetic variation. , 1998, Genome research.

[10]  S. Asa,et al.  The cytogenesis and pathogenesis of pituitary adenomas. , 1998, Endocrine reviews.

[11]  A. Lania,et al.  G protein abnormalities in pituitary adenomas , 1998, Molecular and Cellular Endocrinology.

[12]  K. Mayo,et al.  Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins. , 1998, Molecular endocrinology.

[13]  S. Amselem,et al.  Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. , 1998, The Journal of clinical endocrinology and metabolism.

[14]  H. Schulte,et al.  Structure and regulation of the human growth hormone-releasing hormone receptor gene. , 1998, Molecular endocrinology.

[15]  H. Maheshwari,et al.  The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH‐releasing hormone receptor gene , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[16]  Roy G. Smith,et al.  Peptidomimetic regulation of growth hormone secretion. , 1997, Endocrine reviews.

[17]  P. Rocmans,et al.  Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  M. Stoler,et al.  Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. , 1997, The American journal of pathology.

[19]  R. Scully,et al.  A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. , 1997, The Journal of clinical endocrinology and metabolism.

[20]  P. Godfrey,et al.  The Growth‐Hormone‐Releasing Hormone Receptor: Signal Transduction, Gene Expression, and Physiological Function in Growth Regulation a , 1996, Annals of the New York Academy of Sciences.

[21]  T. Ohnishi,et al.  Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.

[22]  P. Chanson,et al.  The cyclic adenosine 3',5'-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. , 1995, Molecular endocrinology.

[23]  S. Swillens,et al.  Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades. , 1995, Molecular endocrinology.

[24]  K. Chihara,et al.  Human TRH receptor messenger ribonucleic acid levels in normal and adenomatous pituitary: analysis by the competitive reverse transcription polymerase chain reaction method , 1995, Clinical endocrinology.

[25]  H. Watanobe,et al.  Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly , 1995, Neuropeptides.

[26]  A. Colao,et al.  Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies. , 1994, European journal of endocrinology.

[27]  H. Watanobe,et al.  Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly , 1993, Neuropeptides.

[28]  T. Satoh,et al.  Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene. , 1993, Biochemical and biophysical research communications.

[29]  Aldons J. Lusis,et al.  Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.

[30]  C. Francomano,et al.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Sawchenko,et al.  Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant , 1991, Nature.

[32]  F. Bloom,et al.  Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene , 1991, Nature.

[33]  K. Kovacs,et al.  Clonal origin of pituitary adenomas. , 1990, The Journal of clinical endocrinology and metabolism.

[34]  S. Asa,et al.  Pituitary Mammosomatotroph Adenomas Develop in Old Mice Transgenic for Growth Hormone-Releasing Hormone , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  T. Sano,et al.  Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. , 1988, Endocrine reviews.

[36]  G. Giannattasio,et al.  Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas , 1987, Nature.

[37]  K. Kovacs,et al.  Pathology of growth hormone-producing tumors of the human pituitary. , 1986, Seminars in diagnostic pathology.

[38]  B. Scheithauer,et al.  A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. , 1984, The Journal of clinical endocrinology and metabolism.

[39]  A. Spiegel,et al.  Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. a cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells. , 1983, The Journal of clinical investigation.

[40]  N. Ling,et al.  Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. , 1982, Science.

[41]  J. Bertherat Nuclear effects of the cAMP pathway activation in somatotrophs. , 1997, Hormone research.

[42]  S. Chua,et al.  Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse , 1996, Nature Genetics.

[43]  Riccardo Fodde,et al.  Mutation detection by denaturing gradient gel electrophoresis (DGGE) , 1994, Human mutation.

[44]  M. Thorner,et al.  Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. , 1993, Molecular endocrinology.

[45]  V. Sheffield,et al.  Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Thomas A. Kunkel,et al.  Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  N. Ling,et al.  Plasma growth hormone response to growth hormone-releasing factor in acromegalic patients. , 1984, The Journal of clinical endocrinology and metabolism.

[48]  N. Ling,et al.  Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. , 1984, The Journal of clinical endocrinology and metabolism.